These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7743382)

  • 1. Estrogen use and cancer incidence: a review.
    Lupulescu A
    Cancer Invest; 1995; 13(3):287-95. PubMed ID: 7743382
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.
    Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
    Aust N Z J Public Health; 2015 Oct; 39(5):434-40. PubMed ID: 26437728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy.
    Barrett-Connor E
    BMJ; 1998 Aug; 317(7156):457-61. PubMed ID: 9703530
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers.
    Chen K; Zhang J; Beeraka NM; Tang C; Babayeva YV; Sinelnikov MY; Zhang X; Zhang J; Liu J; Reshetov IV; Sukocheva OA; Lu P; Fan R
    Front Oncol; 2022; 12():820968. PubMed ID: 35814391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception matters: Stressful life events increase breast cancer risk.
    Fischer A; Ziogas A; Anton-Culver H
    J Psychosom Res; 2018 Jul; 110():46-53. PubMed ID: 29764605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Hyaluronic Acid Vaginal Cream and Conjugated Estrogen Used in Treatment of Vaginal Atrophy of Menopause Women: A Randomized Controlled Clinical Trial.
    Jokar A; Davari T; Asadi N; Ahmadi F; Foruhari S
    Int J Community Based Nurs Midwifery; 2016 Jan; 4(1):69-78. PubMed ID: 26793732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal and reproductive risk factors associated with breast cancer in Isfahan patients.
    Tazhibi M; Dehghani M; Babazadeh S; Makkarian F; Tabatabaeian M; Sadeghi M; Rezaei P; Faghihi M
    J Educ Health Promot; 2014; 3():69. PubMed ID: 25077162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein, a soy phytoestrogen, reverses severe pulmonary hypertension and prevents right heart failure in rats.
    Matori H; Umar S; Nadadur RD; Sharma S; Partow-Navid R; Afkhami M; Amjedi M; Eghbali M
    Hypertension; 2012 Aug; 60(2):425-30. PubMed ID: 22753213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens.
    Wang Z; Chandrasena ER; Yuan Y; Peng KW; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2010 Aug; 23(8):1365-73. PubMed ID: 20509668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats.
    Singh B; Mense SM; Remotti F; Liu X; Bhat HK
    J Biochem Mol Toxicol; 2009; 23(3):202-11. PubMed ID: 19526586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a liquid chromatography electrospray ionization tandem mass spectrometry method for analysis of stable 4-hydroxyequilenin-DNA adducts in human breast cancer cells.
    Wang Z; Edirisinghe P; Sohn J; Qin Z; Geacintov NE; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2009 Jun; 22(6):1129-36. PubMed ID: 19368368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus.
    Wang Z; Wijewickrama GT; Peng KW; Dietz BM; Yuan L; van Breemen RB; Bolton JL; Thatcher GR
    J Biol Chem; 2009 Mar; 284(13):8633-42. PubMed ID: 19158089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational properties of equilenin-DNA adducts: stereoisomer and base effects.
    Ding S; Shapiro R; Cai Y; Geacintov NE; Broyde S
    Chem Res Toxicol; 2008 May; 21(5):1064-73. PubMed ID: 18416538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential mechanisms of estrogen quinone carcinogenesis.
    Bolton JL; Thatcher GR
    Chem Res Toxicol; 2008 Jan; 21(1):93-101. PubMed ID: 18052105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
    Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
    J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-hydroxyequilenin-adenine lesions in DNA duplexes: stereochemistry, damage site, and structure.
    Ding S; Shapiro R; Geacintov NE; Broyde S
    Biochemistry; 2007 Jan; 46(1):182-91. PubMed ID: 17198388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of human mammary epithelial cells to DNA damage induced by 4-hydroxyequilenin: Lack of p53-mediated G1 arrest.
    Cuendet M; Bolton JL
    Chem Biol Interact; 2006 Jul; 161(3):271-8. PubMed ID: 16730688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors.
    Sun Y; Gu C; Liu X; Liang W; Yao P; Bolton JL; van Breemen RB
    J Am Soc Mass Spectrom; 2005 Feb; 16(2):271-9. PubMed ID: 15694777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women: a case-control study.
    Oran B; Celik I; Erman M; Baltali E; Zengin N; Demirkazik F; Tezcan S
    Med Oncol; 2004; 21(1):31-40. PubMed ID: 15034211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefits.
    Higa GM
    Pharmacoeconomics; 2000 Feb; 17(2):121-32. PubMed ID: 10947336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.